Epic Medical Research Joins hyperCORE International's Global Partner Site Network
August 5th, 2025 7:00 AM
By: Newsworthy Staff
Epic Medical Research's inclusion in hyperCORE International's network enhances global clinical trial capabilities and patient outcomes through shared resources and expertise.

Epic Medical Research has become a part of hyperCORE International's global partner site network, a move that significantly expands the clinical research organization's capabilities and reach. Based in Dallas, Texas, Epic operates across 12 state-of-the-art locations in four states, offering comprehensive clinical trial services across various therapeutic areas. This partnership is expected to bring about transformative advancements in clinical research, leveraging shared expertise and resources to improve patient outcomes.
Dr. Haresh Boghara, President & Principal Investigator at Epic, expressed enthusiasm about the collaboration, highlighting the mutual commitment to advancing clinical research. The partnership with hyperCORE International provides Epic with access to a broader platform for delivering innovative clinical trial solutions, enhancing the quality and efficiency of research endeavors.
Nicholas Focil, President of hyperCORE International, welcomed Epic Medical Research into the network, noting the organization's significant contributions to therapeutic breadth and operational scale. The alignment of Epic's commitment to quality and innovation with hyperCORE's mission is poised to elevate trial performance across the network, fostering streamlined operations and accelerated results in clinical research.
hyperCORE International, founded in 2019, is a network of leading clinical research site organizations with over 80 active trial sites across five countries and two continents. The network's collaborative framework is designed to optimize efficiency, standardization, and excellence in clinical research, having completed more than 7,000 studies involving over 140,000 randomized participants. This partnership underscores hyperCORE's dedication to advancing clinical research through ethical, timely studies and superior retention, supported by its members' accolades for performance, quality, and innovation.
For more information on hyperCORE International, visit https://www.hypercoreinternational.com.
Source Statement
This news article relied primarily on a press release disributed by 24-7 Press Release. You can read the source press release here,
